FPH.NZ Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 06:59):

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide...

Stats
Dagens volum	1.23M
Gjennomsnittsvolum	413 957
Markedsverdi	16.35B
EPS	NZD0 ( 2023-11-28 )
Neste inntjeningsdato	( NZD0 ) 2024-05-23
Last Dividend	NZD0 ( N/A )
Next Dividend	NZD0 ( N/A )
P/E	62.20
ATR14	NZD0.00900 (0.03%)

Volum Korrelasjon

Lang: 0.02 (neutral)

Kort: -1.00 (very strong negative)

Signal:(49.974) Neutral

Fisher & Paykel Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Fisher & Paykel Korrelasjon - Valuta/Råvare

-0.06
( neutral )

-0.22
( neutral )

0.00
( neutral )

-0.26
( neutral )

-0.69
( moderate negative )

-0.20
( neutral )

Fisher & Paykel Økonomi

Annual	2023
Omsetning:	NZD1.59B
Bruttogevinst:	NZD945.90M (59.54 %)
EPS:	NZD0.430

FY	2023
Omsetning:	NZD1.59B
Bruttogevinst:	NZD945.90M (59.54 %)
EPS:	NZD0.430

FY	2022
Omsetning:	NZD1.64B
Bruttogevinst:	NZD1.01B (61.70 %)
EPS:	NZD0.650

Financial Reports:

No articles found.

Fisher & Paykel

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. In addition, it provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.